Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches
Anemia is common in cancer patients and impacts on quality of life and prognosis. It is typically multifactorial, often involving different pathophysiological mechanisms, making treatment a difficult task. In patients undergoing active anticancer treatments like chemotherapy, decreased red blood cel...
Main Authors: | Claudia Bozzini, Fabiana Busti, Giacomo Marchi, Alice Vianello, Claudio Cerchione, Giovanni Martinelli, Domenico Girelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1380358/full |
Similar Items
-
Iron deficiency in the elderly population, revisited in the hepcidin era
by: Fabiana eBusti, et al.
Published: (2014-04-01) -
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels
by: Acaynne Lira Zidanes, et al.
Published: (2020-11-01) -
COBALAMIN DEFICIENCY IN THE ELDERLY
by: Giacomo Marchi, et al.
Published: (2020-06-01) -
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis
by: Giacomo Marchi, et al.
Published: (2019-04-01) -
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies
by: Fabiana Busti, et al.
Published: (2025-01-01)